盘前必读丨A股迎来多重利好；国家医保商保“双目录”公布

Group 1 - The year-end market is expected to experience rapid rotation, primarily maintaining a volatile structure [1][15][16] - The A-share market has achieved reasonable growth in volume and effective improvement in quality [6] - The Nasdaq China Golden Dragon Index increased by 1.29%, with notable gains from companies like Dingdong Maicai and Baidu [4] Group 2 - The U.S. stock market saw moderate gains, with the Dow Jones up 0.22% and the S&P 500 up 0.19% [4] - Major tech companies showed mixed performance, with Microsoft and Google gaining while Apple declined [4] - The WTI crude oil futures rose by 0.69% to $60.08, marking a weekly increase of 2.61% [4] Group 3 - The State Council is focusing on energy conservation and carbon reduction, along with regulatory measures for administrative law enforcement [6] - The China Securities Regulatory Commission (CSRC) emphasizes the importance of long-term and value investment products [6][8] - The National Financial Supervision Administration has adjusted risk factors for insurance companies, lowering certain risk factors for long-term holdings [7] Group 4 - The Ministry of Commerce is promoting consumer spending and expanding the market for durable goods [10] - The new drug directory for national medical insurance will be implemented starting January 1, 2026, with 114 new drugs added [12] - The online liquor market is projected to grow significantly, with a GMV of approximately 150 billion yuan in 2024 [13]